Organization · Private Equity
DM Healthcare Investment
DM Healthcare Investment is a globally-managed healthcare fund based in multiple cities including Shenzhen, Hong Kong, Zurich, Boston, and Toronto. The organization focuses on investing in organ regeneration technology and related sectors to address end-stage organ diseases.
Overview
What DM Healthcare Investment does
What DM Healthcare Investment is
DM Healthcare Investment is a globally-managed healthcare fund based in multiple cities including Shenzhen, Hong Kong, Zurich, Boston, and Toronto. The organization focuses on investing in organ regeneration technology and related sectors to address end-stage organ diseases.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2003
- Approximate age
- About 23 years
- Structured capabilities
- Funder
- Last reviewed
- March 5, 2026
Official channels
Find DM Healthcare Investment elsewhere
Open the official website or a supported primary organization account.
Capability profile
DM Healthcare Investment as a funder
Investment thesis
DM Healthcare Investment focuses on funding companies that specialize in Organ Repair and Rebuilding technologies. Their strategy includes enhancing corporate governance and optimizing operational models of portfolio companies.
Focus narrative
DM Healthcare Investment primarily invests in companies involved in Organ Repair and Rebuilding technologies. Their investment strategy includes a focus on pharmaceuticals, medical devices, and medical services. The organization aims to enhance the corporate governance and business strategies of its portfolio companies, optimize their operational models, and improve their capital structures.
Focus and fit
- Regions
- Asia · Europe · Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 15
Portfolio context
Notable portfolio companies include: RegeNephro (Kyoto, JP): A regenerative medicine company focused on renal failure treatments using Nephron progenitor cells (NPCs). Humacyte (North Carolina, USA): Develops bioengineered human tissues for various clinical needs. Huanova (Shenzhen, CN): Produces high-quality hydrogel medical devices for applications such as hemostasis and dental repair. Iviva Medical (Boston, USA): Focuses on regenerative medicine solutions for late-stage kidney failure and diabetes. uLab Systems (San Francisco, USA): An AI treatment software company for dental applications. Asia Regenerative Medicine (ARM) (Shenzhen, CN): Engages in regenerative medicine research and commercialization, including artificial organ development. Asia Kidney Rebuilding (Guangzhou, CN): Works on renal cell production and artificial kidney scaffold development. Broncus Medical (San Jose, USA): Specializes in innovative lung solutions and interventional pulmonology. Convergence Biomanufacturing Ltd. (ConvBio) (Shenzhen, CN): Develops technologies for tissue assembly and drug discovery. Riton Biomanufacturing Co., Ltd. (Guangzhou, CN): Produces orthodontic braces and 3D printers for the dental market. China Biotech Services Holdings Ltd.: A leader in dental supply and healthcare products. Angel Align: A leading Chinese company in the Invisalign market. Wego Medical: The largest medical consumables producer in China. Sigilon Therapeutics (Massachusetts, USA): Develops functional cures for various diseases using human cell technology. Miromatrix Medical (Minnesota, USA): Focuses on bioengineering transplantable human organs. Rain Biotech Solutions Limited (Shatin, Hong Kong SAR): Specializes in AI-driven cell sorting and imaging equipment. Asia Pharma Tech (Guangzhou, CN): Engaged in drug discovery and development focusing on organ and cell regeneration.
Common questions
What to know about DM Healthcare Investment
Upseed classifies DM Healthcare Investment under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.